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Abstract
Introduction: Serum potassium levels have been shown in some animal studies to be associated with the 
process of atherosclerosis. We decided to assess the correlation of serum potassium level in ischemic heart disease 
patients with disease severity and its relationship with prognosis in terms of major acute cardiac events (MACE). 
Material and methods: This was a cross-sectional cohort study carried out at cardiology department of Rehman 
Medical Institute, from July 2016 to 31st Aug. 2018 a period of 26 months. 622 patients were included in the 
study. Clinical and angiographic characteristics were assessed based on the serum potassium level. Correlation of 
serum potassium level with Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery 
(SYNTAX) and Gensini scores was also evaluated. Follow up for MACE was carried out after one year.
Results: Mean serum potassium level was 3.93 ± 0.95 (mEq/l) in coronary artery disease patients. Serum 
potassium level showed negative correlation with SYNTAX score (r = –0.60, p < 0.05) and Gensini score 
(r = –0.64, p < 0.05). There was also a significant difference between low and high potassium level in relation 
to the multi-vessel disease on coronary angiography (p < 0.05). Low potassium level was a good predictor of 
adverse outcomes as shown by Kaplan-Meier analysis. Multivariate Cox regression analysis showed that serum 
potassium level and diabetes were independent predictors of MACE (p < 0.05). 
Conclusion: Low serum potassium level is correlated with more severe coronary atherosclerosis. Low potassium 
levels are associated with significantly poor outcomes.
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Introduction 
Cardiovascular disease is the leading cause of morbidity 
and mortality globally [1]. A lot of research is underway 
to better understand the causes of cardiovascular dis-
ease as well as the means to reduce such an alarming 
incidence. One such modifiable factor which has come 
under light recently is serum potassium level.
Hypokalemia has multiple effects on the myocardi-
um and predisposes to arrhythmias while on the other 
hand hyperkalemia slows down conduction [2]. 
Studies have shown that elevated potassium levels 
induce arterial smooth muscle relaxation and cause 
vasodilatation due to involvement of K+ channels and 
Na+/K+-ATPase [3–6]. Elevated serum potassium 
levels also play a role in the inhibition of platelet ag-
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gregation and arterial thrombus formation, and hence 
coronary atherosclerosis [7–10]. 
However, a few recent studies [11, 12] have demon-
strated the correlation between elevated serum po-
tassium levels and increased atherosclerosis as well as 
the severity of coronary artery disease, which would 
contradict the above-given explanations. So, keeping 
in mind the results of such studies, we hypothesized 
that lower serum potassium may be associated with an 
increased risk of cardiovascular events and mortality.
Material and methods 
This was a cross-sectional (for correlation) and co-
hort (for MACE) study carried out at cardiology depart-
ment of Rehman Medical Institute, Peshawar, which is 
one of the biggest tertiary care hospitals in KPK, Pakistan 
providing 24/7 cath. lab facility, from July 2016 to August 
2018, a period of 26 months. A total of 622 patients were 
included in the study population using universal sampling 
technique. All those patients were included who gave 
consent for inclusion and were admitted or discharged 
with the diagnosis of ischemic heart disease fulfilling the 
criteria of either stable angina, unstable angina or myo-
cardial infarction [13]. Patients who were admitted due 
to non-cardiac causes like severe pneumonia, ARDS, and 
renal failure were excluded from the study population. 
All baseline demographic characteristics including age, 
gender, diabetes, hypertension, body mass index (BMI), 
smoking, alcohol consumption, and medication use were 
noted for each patient from history and hospital records. 
For measured variables, blood samples were taken at 
admission and sent for analysis of serum potassium, 
hemoglobin level, troponin level, CRP level, creatinine, 
and urea, total cholesterol (TC), low-density lipopro-
tein cholesterol (LDL), triglyceride (TG), high-density 
lipoprotein cholesterol (HDL) levels (Cobas B221 and 
6000, Roche-Switzerland). All cases were divided into 
two groups (Low and High potassium groups) based on 
median serum potassium levels.
Definition of risk factors  
and clinical syndromes 
Hypercholesterolemia was diagnosed in patients 
who had been given lipid-lowering medication or had a 
history of total cholesterol levels > 200 mg/dl [14]. Pa-
tients were diagnosed as hypertensive if they were doc-
umented to have a systolic blood pressure 140 mm Hg 
or a diastolic blood pressure 90 mm Hg on more than 
two occasions (but not during the angiogram proce-
dure) or were already on antihypertensive therapy [15]. 
Patients were diagnosed with diabetes mellitus if they 
had a documented fasting glucose value > 126 mg/dl 
or HbA1C of >7 on one or more occasion or were tak-
ing insulin or oral hypoglycemic medications for diabe-
tes mellitus. Myocardial infarction (MI) on presentation 
was diagnosed by a history of chest pain, electrocar-
diogram showing new ST-segment/T wave changes or 
new pathological Q waves or new left bundle branch 
block (LBBB), echocardiographic evidence of new 
regional wall motion abnormality and two recordings 
of hs-troponin levels showing rise and/or fall in values 
with at least one value above 99th percentile upper 
reference limit (URL). Body mass index was calculated 
by dividing the weight of the patient in kilograms by 
the square of height in meters. Active Smokers were 
defined as someone who smoked > 100 cigarettes, 
cigars, or pipes in their lifetime and still smoked in the 
last 28 days. Smokers were classified as former only if 
they had smoked > 100 cigarettes, cigars, or pipes in 
their lifetime and has not smoked in the last 28 days 
preceding the date of angiography [16]. 
Angiographic evaluation
Coronary angiography was performed with Selding-
er technique in all the patients [17]. All angiographic 
assessments were done by two independent cardiolo-
gists. In case of difference in opinion, a third cardiologist 
was consulted. Patients were then divided into a con-
trol group (normal coronary vessels) and cases group 
(coronary arteries with the disease). Control group 
included 100 subjects and 622 cases with coronary 
artery stenosis ≥ 50% of the vessel diameter were 
included in the CAD group (622 cases: 371 men and 
251 women). SYNTAX and Gensini scoring systems 
were used to assess the severity of coronary stenosis 
in all cases. In SYNTAX score calculation each coronary 
lesion producing ≥ 50% diameter stenosis in vessels 
≥ 1.5 mm was scored separately using the SYNTAX 
score algorithm available on the Internet from the and 
added to obtain the overall SYNTAX score. Gensini 
score is based on the severity of lesion narrowing, 
number of lesions, lesion location, and influence of 
collaterals [18, 19]. 
Major adverse cardiac events (MACE) for the pur-
poses of follow-up were as follows: (1) acute myocardial 
infarction; (2) decompensated heart failure; (3) target 
vessel revascularization and (4) mortality due to cardiac 
disease [20]. 
This study was evaluated and approved by the Re-
search evaluation and Ethics Committee of Rehman Med-
ical Institute. The study abided by the principles of the 
Declaration of Helsinki. Written and informed consent 
was obtained from each patient included in the study.
Statistical analysis
Data were analyzed for normality using the Kolmogo-
rov-Smirnov (KS) test. Continuous data are presented 
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as means ± SD Between-group comparisons were 
performed using t-test. Categorical data were pre-
sented as percentages and analyzed using c2 test. The 
correlation between serum potassium level, Syntax and 
Gensini scores were examined by Pearson correlation 
analysis. and Kaplan Meyer analysis was used for sur-
vival analysis. Differences with p values < 0.05 were 
considered statistically significant. Multivariate Cox re-
gression analysis was done to examine the independent 
predictors of MACE
Results
General clinical data comparison
Mean serum potassium level was 3.93 ± 0.95 (mEq/l) 
in coronary artery disease patients. Patients were divided 
based median serum potassium level (4 mEq/l) and com-
parison was made of baseline characteristics. There were 
no significant differences in clinical characteristics at base-
line between the two groups with high and low potassium 
levels (p > 0.05) (Table 1). All patients received similar 
medication such as anti-platelets, beta-blockers, Renin An-
giotensin Aldosterone system (RAAS) inhibitors, statins, ni-
trates and diuretics. Patients’ characteristics with and with-
out MACE were also compared which showed a significant 
difference in serum potassium level, BMI, ejection fraction, 
SYNTAX score, Gensini Score and multi-vessel disease 
(p ≤ 0.05) (Table 2).
Angiographic assessment and correlation
Angiographic analysis based on serum potassium level 
demonstrated that there was a significant difference 
Table 1. Baseline characteristics and angiographic features of study groups based on serum potassium levels
Variable Serum potassium (< 4 mEq/l) Serum potassium (4 mEq/l or above)
Number of patients 349 273
Age (years) 63.72 ± 4.35 62.54 ± 10.23
Gender (m/f) 210/139 (60/40%) 161/112 (59/41%)
Ejection fraction (%) 49.98 ± 10.55 49.87 ± 10.35
Blood sugar 147.31 ± 96.06 146.40 ± 80.14 
Serum creatinine 1.01 ± 0.23 1.01 ± 0.22 
Hemoglobin (g/dl) 14.2 ± 1.71 14.39 ± 1.72
BNP (pg/ml) 395.12 ± 629.35 487.12 ± 800.72
Hs-Troponin 3443 ± 4414 4584 ± 5796 
CRP 8.00 ± 11.19 7.91 ± 10.59
Diabetes 122 (35%) 85 (31%)
Hypertension 192 (55%) 158 (58%)
Smoking 105 (30%) 90 (33%)
Hyperlipedemia 98 (28%) 68 (25%)
Anti-Platelet drugs 345 (99%) 273 (100%)
Beta blocker 311 (89%) 235 (86%)
RAAS inhibitors 195 (56%) 145 (53%)
Nitrates 188 (54%) 156 (57%)
Digoxin 70 (20%) 49 (18%)
Diuretics 70 (20%) 46 (17%)
Lipid lowering agents 209 (60%) 169 (62%)
SYNTAX score 37.48 ± 7.28 26.76 ± 6.34*
Gensini score 77.56 ± 13.05 56.46 ± 12.24*




*P ≤ 0.05; CRP: C-reactive protein; RAA: renin angiotensin aldosterone system inhibitors; LAD: left anterior descending artery; LCX: left circumflex artery; RCA: 
right coronary artery
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between low and high potassium level groups in terms 
of multi-vessel disease, SYNTAX score and Gensini 
score (p < 0.05). The involvement of the type of vessel 
was similar in both groups (p > 0.05) (Table 1).
The mean SYNTAX score all patients was 32.78 ± 
8.70 while the Gensini score was 68.30 ± 16.46. The 
results of Pearson’s correlation indicate that there was 
a significant negative correlation between the concentra-
tion of potassium and SYNTAX score (r = –0.60, p < 0.05). 
and Gensini score (r= –0.64, p < 0.05) (Fig. 1).
Survival and multivariate analysis for MACE 
For analysis, we assessed Kaplan-Meier curves accord-
ing to median value of serum Potassium level (median 
= 4 mEq/l) (Fig. 2). The Kaplan-Meier curves revealed 
a significantly worse cumulative outcome in patients 
with serum Potassium level below 4 mEq/l.
Cumulative MACE for this study was 3.4% (21 pa-
tients). The 180 days mortality was 1.28% (8 patient), 
myocardial infarction 1.76% (11 patients), target vessel 
revascularization was 1.1% (7 patients) and cardiac 
failure was 1.1% (7 patients) (Tables 3, 4).
Discussion
Data from the Systolic Hypertension in the Elderly 
Program (SHEP) [21] trial has shown that normal 
potassium level has significantly reduced hazard ration 
Table 2. Patient characteristics and angiographic features of study groups according to MACE
Variable Patients without MACE Patients with MACE
Number of patients 601 21
Age (years) 61.35 ± 5.62 63.32 ± 8.46
Gender (m/f) 330/271 (55/45%) 12/9 (60/41%)
Serum potassium (< 4 mEq/l) 3.38 ± 0.44 4.62 ± 0.56*
BMI 22.43 ± 1.12 25.11 ± 1.15*
Ejection fraction (%) 54.51 ± 8.14 42.35 ± 7.29*
Blood sugar 140.31 ± 87.27 148.40 ± 72.44 
Serum creatinine 1.11 ± 0.35 1.23 ± 0.28 
Hemoglobin (g/dl) 13.4 ± 1.53 14.38 ± 1.67
BNP (pg/ml) 346.19 ± 601.45 501.17 ± 780.58
Hs-troponin 3566 ± 3942 4731 ± 5385 
CRP 6.00 ± 9.12 8.34 ± 11.89
Diabetes 222 (37%) 13 (62%)*
Hypertension 301 (50%) 12 (57%)
Smoking 186 (31%) 7 (35%)
Hyperlipedemia 144 (24%) 6 (29%)
Anti-platelet drugs 601 (100%) 20 (95%)
Beta blocker 541(90%) 18 (86%)
RAAS inhibitors 330 (55%) 11 (54%)
Nitrates 330 (55%) 12 (57%)
Digoxin 108 (18%) 4 (20%)
Diuretics 150 (25%) 6 (30%)
Lipid lowering agents 360 (60%) 13 (62%)
SYNTAX score 25.48 ± 6.24 39.76 ± 7.37*
Gensini score 57.56 ± 12.16 79.46 ± 10.43*




*P ≤ 0.05; CRP: C-reactive protein; RAA: renin angiotensin aldosterone system inhibitors; LAD: left anterior descending artery; LCX: left circumflex artery; RCA: 
right coronary artery
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for cardiovascular events including stroke and coro-
nary vessels related events. Moreover, animal studies 
have shown that high potassium diets normalize blood 
pressure and provide protection against atherosclerosis 
in arteries [22].
Increased potassium content in diets plays a role 
reduction of vascular lesions owing to decreased en-
dothelial injuries and less adherence and infiltration of 
macrophages into the vascular wall [11]. 
Other mechanisms explaining the role of increased 
potassium levels in the maintenance of normal blood 
pressure as well as prevention of coronary atheroscle-
rosis are as follows; a) inhibition of platelet aggregation 
and arterial thrombosis; b) reduction in renal vascular 
resistance and increase in glomerular filtration rate; 
Figure 1. Correlation of serum potassium level with (a) SYNTAX score and (b) Gensini score. Pearson’s correlation analysis show 
negative correlation for both [SYNTAX score (r = –0.06) and Gensini score (r = – 0.64)]
Figure 2. Kaplan Meier analysis based on median serum po-
tassium level. A significant difference between low and high 
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Table 3. Univariate analysis for MACE
Univariate analysis
HR (95%CI) p value
Gender (M vs. F) 1.131 (0.151–3.167) 0.31
Age (≥ 60 vs. < 60) 0.519 (0.212–1.926) 0.32
Serum potassium  
(≥ 4 mEq/l vs. < 4mEq/l)
1.426 (1.077–1.413) 0.02
Ejection fraction  
(≥ 50% vs. < 50%)
1.242 (0.551–1.236) 0.05
Hypertension (present  
vs. absent)
1.986 (0.191–47.626) 0.45
Diabetes (present  
vs. absent)
1.378 (1.107–1.412) 0.03
BMI (≥ 25 vs. < 25) 0.658 (0.421–1.229) 0.19
Smoking (yes vs. no) 1.716 (0.635–66.137) 0.67
Total cholesterol (≥ 200 
mg/dl vs. < 200 mg/dl)
1.109 (0.229–6.443) 0.75
BNP (≥ 100 pg/ml vs.  
< 100 pg/ml)
0.582 (0.316–1.572) 0.37
Troponin (≥ 14 mg/l vs.  
< 14 ng/l)
0.088 (0.087–1.983) 0.31
Creatinine (≥ 1.2 mg/dl  
vs < 1.2 mg/dl)
0.865 (0.794–1.181) 0.28
Family history of CADc 
(present vs. absent)
1.927 (0.251–59.172) 0.43
Multi-vessel disease  
(present vs. absent)
0.229 (0.026–67.472) 0.14
BMI: body mass index; BNP: basic natriuretic peptide; CAD: coronary artery 
disease
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c) inhibition of free radical formation from vascular en-
dothelial cells and macrophages; d) inhibition of vascular 
smooth muscle cell proliferation; and e) suppression of 
reactive oxygen species overproduction [23]. 
Such established findings are in contradiction to 
two previous studies [11, 12] which have reported that 
hyperkalemia is associated with increased atherosclero-
sis. Multiple factors can affect serum potassium levels 
including renal function, dietary intake, hormonal status, 
renin-angiotensin–aldosterone system, heart failure, 
myocardial infarction and drugs. The major limitation 
in the study conducted by Cavusoglu et al. [11] was 
that they only included subjects of the male gender. 
Diane et al. [24] previously reported that male sex was 
associated with higher potassium levels as compared 
to females. This could have clearly affected the results 
obtained by Cavusoglu and his research team. 
In the second study conducted by Guang et al. [12] 
the study group has no patients with myocardial infarc-
tion. Although studies have shown that in acute stress 
such as myocardial infarction, the potassium level is 
higher due to various mechanisms involving necrosis 
induced activation of aldosterone system and sympa-
thetic-adrenal induced involvement of sodium-potassi-
um pumps [25–27]. But by the exclusion of such group 
from the study also means that patients with more 
severe could not be assessed for the observed results.
We, in our study, not only included subjects of 
both genders but also myocardial infarction patients 
along with patients of chronic and stable coronary 
artery disease. We believe such a study group would 
a better understanding of patients in real-life situation. 
Moreover, we in our study not only assessed severity of 
coronary atherosclerosis not only by Gensini score which 
assesses the severity of coronary vasculature on the an-
atomical basis and has been described elsewhere [19], 
but also SYNTAX score which is well-established sys-
tem for quantification of coronary lesions as well as for 
prediction of major adverse cardiac events (MACE) in 
patients undergoing percutaneous coronary interven-
tion (PCI) [18, 28–30]. Such measures were taken in or-
der to ensure more reliable and comprehensive results.
Limitations
It is a single centered study and was not designed to 
interpret results based on ethnicity and dietary habits. 
Selecting a large population with multi-centered study 
would address such concerns.
Conclusion
Serum potassium level is lower in coronary artery 
disease and is correlated with severity of atheroscle-
rosis on coronary angiography. Serum potassium is an 
independent predictor of adverse outcomes in coronary 
artery disease patients.
Acknowledgement of grant support
This research did not receive any specific grant from 
funding agencies in the public, commercial, or not-for-
profit sectors.
Conflict of interest: 
None.
References:
1. American Heart Association. Heart disease and stroke statistics: 
2005 Update. Dallas, Tex: American Heart Association. 2004.
2. Sica DA, Struthers AD, Cushman WC, et al. Importance of po-
tassium in cardiovascular disease. J Clin Hypertens (Greenwich). 
2002; 4(3): 198–206, doi: 10.1111/j.1524-6175.2002.01728.x, 
indexed in Pubmed: 12045369.
3. Smith PD, Brett SE, Luykenaar KD, et al. KIR channels function 
as electrical amplifiers in rat vascular smooth muscle. J Physiol. 
2008; 586(4): 1147–1160, doi: 10.1113/jphysiol.2007.145474, 
indexed in Pubmed: 18063660.
4. Jin CZi, Kim HS, Seo EY, et al. Exercise training increases inward-
ly rectifying K(+) current and augments K(+)-mediated vaso- 
dilatation in deep femoral artery of rats. Cardiovasc Res. 2011; 
91(1): 142–150, doi: 10.1093/cvr/cvr050, indexed in Pubmed: 
21349874.
5. Haddy FJ, Vanhoutte PM, Feletou M. Role of potassium in reg-
ulating blood flow and blood pressure. Am J Physiol Regul In-
tegr Comp Physiol. 2006; 290(3): R546–R552, doi: 10.1152/
ajpregu.00491.2005, indexed in Pubmed: 16467502.
6. Seo EY, Kim HJ, Zhao ZH, et al. Low K. current in arterial 
myocytes with impaired K-vasodilation and its recovery by 
exercise in hypertensive rats. Pflugers Arch. 2014; 466(11): 
2101–2111, doi: 10.1007/s00424-014-1473-7, indexed in Pu-
bmed: 24557713.
7. Young DB, Lin H, McCabe RD. Potassium’s cardiovascular pro-
tective mechanisms. Am J Physiol. 1995; 268(4 Pt 2): R825–
Table 4. Multivariate regression analysis for MACE
Multivariate analysis
HR (95%CI) p value
BMI (≥ 100 pg/ml vs.  
< 100 pg/ml)
0.481 (0.613–2.754) 0.54
Serum potassium  
(≥ 4 mEq/l vs. < 4 mEq/l)
1.278(1.073–1.662) 0.03
Ejection fraction  
(≥ 50% vs. < 50%)
1.481 (0.737–1.551) 0.32
Diabetes (present  
vs. absent)
1.331 (1.109–1.517) 0.04




Acta Angiol, 2020, Vol. 26, No. 2
www.journals.viamedica.pl/acta_angiologica
R837, doi: 10.1152/ajpregu.1995.268.4.R825, indexed in Pu-
bmed: 7733391.
8. Ando K, Matsui H, Fujita M, et al. Protective effect of dietary 
potassium against cardiovascular damage in salt-sensitive hyper-
tension: possible role of its antioxidant action. Curr Vasc Phar-
macol. 2010; 8(1): 59–63, doi: 10.2174/157016110790226561, 
indexed in Pubmed: 19485915.
9. Tobian L, Jahner TM, Johnson MA. High K diets markedly reduce 
atherosclerotic cholesterol ester deposition in aortas of rats 
with hypercholesterolemia and hypertension. Am J Hypertens. 
1990; 3(2): 133–135, doi: 10.1093/ajh/3.2.133, indexed in Pu-
bmed: 2306340.
10. Zhang Y, Zhu CG, Guo YL, et al. Higher fibrinogen level is inde-
pendently linked with the presence and severity of new-onset 
coronary atherosclerosis among Han Chinese population. PLoS 
One. 2014; 9(11): e113460, doi: 10.1371/journal.pone.0113460, 
indexed in Pubmed: 25426943.
11. Cavusoglu E, Chopra V, Gupta A. Relation of baseline serum potas-
sium levels to angiographic findings in patients with known or sus-
pected coronary artery disease. Am J Hypertens. 2009; 22: 754–762.
12. Guang Xian Zhao, Xiang Lan Jin, Ji Long Kang, Chun Zi Jin. Se-
rum potassium levels are associated with coronary artery lesion 
severity in coronary artery disease. Int J Clin Exp Med. 2016; 
9(2): 3705–3710.
13. Thygesen K, Alpert JS, Jaffe AS, et al. Joint ESC/ACCF/AHA/
WHF Task Force for the Universal Definition of Myocardial 
Infarction. Third universal definition of myocardial infarction. 
Circulation. 2012; 126(16): 2020–2035, doi: 10.1161/CIR.
0b013e31826e1058, indexed in Pubmed: 22923432.
14. Catapano AL, Graham I, De Backer G, et al. ESC Scientific Doc-
ument Group. 2016 ESC/EAS Guidelines for the Management 
of Dyslipidaemias. Eur Heart J. 2016; 37(39): 2999–3058, doi: 
10.1093/eurheartj/ehw272, indexed in Pubmed: 27567407.
15. Williams B, Mancia G, Spiering W, et al. Authors/Task Force 
Members:, ESC Scientific Document Group . 2018 ESC/ESH 
Guidelines for the management of arterial hypertension. Eur 
Heart J. 2018; 39(33): 3021–3104, doi: 10.1093/eurheartj/
ehy339, indexed in Pubmed: 30165516.
16. https://www.health.govt.nz/our-work/preventative health well-
ness/tobacco control/tobacco-control information-practition-
ers/definitions smoking-status.
17. https://www.medscape.com/answers/80279-119321/what is 
the seldinger technique for femoral central venous access and 
how is it performed.
18. Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the 
SYNTAX score in patients with acute coronary syndromes un-
dergoing percutaneous coronary intervention: analysis from the 
ACUITY (Acute Catheterization and Urgent Intervention Triage 
StrategY) trial. J Am Coll Cardiol. 2011; 57(24): 2389–2397, 
doi: 10.1016/j.jacc.2011.02.032, indexed in Pubmed: 21658558.
19. Gensini GG. A more meaningful scoring system for determining 
the severity of coronary heart disease. Am J Cardiol. 1983; 
51(3): 606, doi: 10.1016/s0002-9149(83)80105-2, indexed in 
Pubmed: 6823874.
20. Ahn MJ, Kim MC, Ahn Y, et al. Impact of Complete Revascular-
ization on Six-Year Clinical Outcomes and Incidence of Acute 
Decompensated Heart Failure in Patients With ST-Segment 
Elevation Myocardial Infarction and Multivessel Coronary Artery 
Disease. Am J Cardiol. 2018; 121(5): 544–551, doi: 10.1016/j.
amjcard.2017.11.025, indexed in Pubmed: 29325904.
21. Franse LV, Pahor M, Di Bari M, et al. Hypokalemia associat-
ed with diuretic use and cardiovascular events in the Systol-
ic Hypertension in the Elderly Program. Hypertension. 2000; 
35(5): 1025–1030, doi: 10.1161/01.hyp.35.5.1025, indexed in 
Pubmed: 10818057.
22. Tobian L. Protecting arteries against hypertensive inju-
ry. Clin Exp Hypertens A. 1992; 14(1-2): 35–43, doi: 
10.3109/10641969209036169, indexed in Pubmed: 1541045.
23. Li X, Li Y, Jin J, et al. Increased serum cathepsin K in patients 
with coronary artery disease. Yonsei Med J. 2014; 55(4): 912–
–919, doi: 10.3349/ymj.2014.55.4.912, indexed in Pubmed: 
24954318.
24. Wysowski DK, Kornegay C, Nourjah P, et al. Sex and age dif-
ferences in serum potassium in the United States. Clin Chem. 
2003; 49(1): 190–192, doi: 10.1373/49.1.190, indexed in Pu-
bmed: 12507983.
25. Goyal A, Spertus JA, Gosch K, et al. Serum potassium levels and 
mortality in acute myocardial infarction. JAMA. 2012; 307(2): 
157–164, doi: 10.1001/jama.2011.1967, indexed in Pubmed: 
22235086.
26. Sekiyama H, Nagoshi T, Komukai K. et.al. Transient decrease in 
serum potassium level during ischemic attack of acute coronary 
syndrome: paradoxical contribution of plasma glucose level and 
glycohemo¬globin. Cardiovasc Diabetol. 2013; 12: 4.
27. Zhang H, Zhou CY. and Fu HY. The level of potassium in early 
patients with acute myocardial infarction and the analysis of its 
relevant factors. Chinese Journal of Prevention and Control of 
Chronic Diseases. 2011; 3: 026.
28. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: 
an angiographic tool grading the complexity of coronary artery 
disease. EuroIntervention. 2005; 1(2): 219–227, indexed in Pu-
bmed: 19758907.
29. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX 
score in the Syntax study. EuroIntervention. 2009; 5(1): 50–56, 
doi: 10.4244/eijv5i1a9, indexed in Pubmed: 19577983.
30. Kato S, Saito N, Kirigaya H, et al. Incremental prognostic value 
of the SYNTAX score to late gadolinium-enhanced magnet-
ic resonance images for patients with stable coronary artery 
disease. Heart Vessels. 2016; 31(6): 871–880, doi: 10.1007/
s00380-015-0685-x, indexed in Pubmed: 25904244.
